Abstract:Background: Special AT-rich sequence binding protein 1 (SATB1) is a chromatin organizer and transcriptional regulator which regulate numerous cellular processes through effects on multiple gene expression. SATB1 is associated with drug resistance in several cancers. Whether SATB1 involves radiation resistance in nasopharyngeal carcinoma (NPC) and underlying mechanism of SATB1 to participate in chemoradiotherapy resistance in NPC have not been elaborated.Methods: Chemoradioresistant NPC cell lines 5-8F/DDP (cisplatin) and 5-8F/R (radiation) were developed from 5-8F cell line. The expressions of SATB1, MMP-9 and EMT markers (Vimentin and E-cadherin) in these cell lines were examined by reverse transcription-quantitative (RT-q) PCR and western blot (WB) analysis. Cell viabilities of 5-8F/DDP treated with various concentrations of DDP and 5-8F/R irradiated with various doses of X-ray at the indicated time were investigated by MTT test. SATB1 was silenced in 5-8F/DDP and 5-8F/R cells by short hairpin RNA, and then the expressions of SATB1, MMP-9, Vimentin and E-cadherin were evaluated by RT-qPCR and WB analysis; the abilities of cell proliferation and invasion were assessed using MTT and transwell assays, respectively. Drug and radiation resistance assays were performed after SATB1 knockdown and cell viability was detected by MTT method.Results: SATB1, MMP-9 and Vimentin were markedly upregulated in 5-8F/DDP and 5-8F/R cells compared with 5-8F cell, whereas E-cadherin was obviously downregulated. 5-8F/DDP and 5-8F/R cells displayed drug and radiation resistance to DDP or X-irradiation, respectively, while DDP or X-irradiation inhibited 5-8F cell viability in a time- and dose-dependent manner. Subsequently, knockdown of SATB1 resulted in decreased MMP-9 and Vimentin expression and increased E-cadherin expression in 5-8F/DDP and 5-8F/R. Furthermore, silencing of SATB1 suppressed proliferative and invasive abilities of 5-8F/DDP and 5-8F/R cells. Additionally, SATB1 knockdown reduced drug resistance of 5-8F/DDP cell to DDP and decreased radiation resistance of 5-8F/R cell to X-ray.Conclusion: These results suggest that high expression of SATB1 plays an important role in the malignant behavior of NPC and leads to X-radiation and drug resistance in NPC through promoting EMT process and enhancing MMP-9 expression. SATB1 may be a promising therapeutic target for aggressive and chemoradiation resistant NPC.

Silencing Satb1 Inhibits The Malignant Phenotype And Increases Sensitivity Of Human Osteosarcoma U2os Cells To Arsenic Trioxide

Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells

LncRNA SATB2-AS1 Promotes Tumor Growth and Metastasis and Affects the Tumor Immune Microenvironment in Osteosarcoma by Regulating SATB2

Long Noncoding RNA SATB1-AS1 Contributes to the Chemotherapy Resistance Through the Microrna-580/ 2'-5'-oligoadenylate Synthetase 2 Axis in Acute Myeloid Leukemia.

SATB2 Overexpression Promotes the Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma by Up-Regulating NOX4

Special AT-rich Sequence-Binding Protein 1 Promotes Cell Growth and Metastasis in Colorectal Cancer.

Silencing SATB1 with Sirna Inhibits the Proliferation and Invasion of Small Cell Lung Cancer Cells

SATB1 Promotes Tumor Metastasis and Invasiveness in Oral Squamous Cell Carcinoma.

Effects of SOST Gene Silencing on Proliferation, Apoptosis, Invasion, and Migration of Human Osteosarcoma Cells Through the Wnt/β-Catenin Signaling Pathway

SATB2 overexpression promotes oral squamous cell carcinoma progression by up-regulating NOX4

Upregulation of SATB1 is Associated with the Development and Progression of Glioma

Overexpression And Involvement Of Special At-Rich Sequence Binding Protein 1 In Multidrug Resistance In Human Breast Carcinoma Cells

SATB1 promotes prostate cancer metastasis by the regulation of epithelial–mesenchymal transition

MicroRNA‑376a Inhibits Cell Proliferation and Invasion in Osteosarcoma Via Directly Targeting SATB1

Silencing XIAP Suppresses Osteosarcoma Cell Growth, and Enhances the Sensitivity of Osteosarcoma Cells to Doxorubicin and Cisplatin.

Effects of Special AT-rich Sequence Binding Protein 1 Silencing Upon the Proliferation of Human Glioma Cells by RNA Interference

Silencing SATB1 Overcomes Temozolomide Resistance by Downregulating MGMT Expression and Upregulating SLC22A18 Expression in Human Glioblastoma Cells

Satb1 Expression Is Associated With Biologic Behavior In Colorectal Carcinoma In Vitro And In Vivo

Overexpression of SENP1 Reduces the Stemness Capacity of Osteosarcoma Stem Cells and Increases Their Sensitivity to HSVtk/GCV

Sirt1 Promotes Metastasis Of Human Osteosarcoma Cells

SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9